Literatur
- 1
Strolin B enedetti M.
Enzyme Induction and Inhibition by new Antiepileptic drugs: a Review of Human Studies.
Fundam Clin Pharmacol.
2000;
14
301-319
- 2
Shenfield G M, Griffin J M.
Clinical Pharmacokinetics of Contraceptive Steroids - An Update.
Clin Pharmacokinet.
1991;
20
15-37
- 3
Orme M, Back D J, Ward S. et al .
The Pharmacokinetics of Ethinylestradiol in the Presence and Absence of Gestodene
and Desogestrel.
Contraception.
1991;
43
305-316
- 4
Balogh A, Gessinger S, Svarovsky U. et al .
Can Oral Contraceptive Steroids Influence the Elimination of Nifedipine and its Primary
Pyridine Metabolite in Humans?.
Eur J Clin Pharmacol.
1998;
54
729-734
- 5
Kuhl H.
Comparative Pharmacology of Newer Progestogens.
Drugs.
1996;
51
188-215
- 6 Reisine T, Pasternak G. Opioid Analgesics and Antagonists. Hardman JG, Limbird LE
Goodman & Gilman’s. The Pharmacological Basis of Therapeutics New York, St. Louis
et al; McGraw Hill 1996: 521-555
Joachim F. Grüner
Eschersheimer Landstraße 396
60433 Frankfurt
Email: gruener.joachim@gruener-domek.de
